CN102526614A - Chinese medicinal kidney healing powder for treating chronic renal failure - Google Patents

Chinese medicinal kidney healing powder for treating chronic renal failure Download PDF

Info

Publication number
CN102526614A
CN102526614A CN2011104628497A CN201110462849A CN102526614A CN 102526614 A CN102526614 A CN 102526614A CN 2011104628497 A CN2011104628497 A CN 2011104628497A CN 201110462849 A CN201110462849 A CN 201110462849A CN 102526614 A CN102526614 A CN 102526614A
Authority
CN
China
Prior art keywords
radix
parts
medicine
renal failure
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011104628497A
Other languages
Chinese (zh)
Other versions
CN102526614B (en
Inventor
王遐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201110462849 priority Critical patent/CN102526614B/en
Publication of CN102526614A publication Critical patent/CN102526614A/en
Application granted granted Critical
Publication of CN102526614B publication Critical patent/CN102526614B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an external Chinese medicinal preparation for treating chronic renal failure. The external Chinese medicinal preparation is powder prepared from epimedium herb, south dodder seed, astragalus, cortex eucommiae, turmeric root-tuber, Chinese angelica, red-rooted salvia root, medicinal indianmulberry root, liquoric root, costus root, white pepper and borneol, is blended into paste by using rice wine, and is externally applied to an umbilical region. Due to the adoption of the external Chinese medicinal preparation, the serum creatinine and urea nitrogen of a patient can be reduced effectively, the renal failure process is delayed, and the clinical symptom is improved; and as proved by clinical test, the total effective rate is 88.8 percent, the side effect is small, severe untoward effects are avoided, and a treatment method is simple.

Description

A kind of Chinese medicine Shenkangsan-medicine for treating nephrosis of treating chronic renal failure
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine external pulvis of treating chronic renal failure.
Background technology
Chronic renal failure is to occur in chronic kidney on the basis of various chronic renal diseases and relevant disease, that slowly occur to go down until a kind of clinical syndrome of depletion.Mainly show as multiple dysbolismus and because each systemic symptom that the metabolite retention is produced.Motherland's medical science thinks, interior be deficiency of kidney-QI, be that the six evils invades outward, with the passing of time nephropathy causes decline of kidney-YANG, Kidney-Yin loss, the function of kidney own day by day fails, negative and positive of qi and blood all consumes.
Along with progress, the growth in the living standard of society, broad masses pay attention to all the more the health problem of self.The sickness rate and the recall rate of chronic renal failure rise gradually, have a strong impact on patient's life quality.Chronic renal failure is a kind of relatively disease of refractory, no matter western medicine still is the problem that all there is weak curative effect in treatment by Chinese herbs.Especially side effect will obviously appear in oral drugs time one length.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine for outer use of treating chronic renal failure.This Chinese medicine for outer use can effectively reduce patient's serum creatinine and blood urea nitrogen, delays the renal failure process, improves clinical symptoms; And side effect is little, no serious adverse reaction, and Therapeutic Method is simple.
The objective of the invention is to realize that through following technical scheme the Chinese medicine Shenkangsan-medicine for treating nephrosis of this treatment chronic renal failure is processed by following parts by weight of Chinese traditional medicine: Herba Epimedii 6-8 part, Semen Cuscutae 1-3 part, Radix Astragali 5-7 part, Cortex Eucommiae 3-5 part, Radix Curcumae 4-6 part, Radix Angelicae Sinensis 5-7 part, Radix Salviae Miltiorrhizae 3-5 part, Radix Morindae Officinalis 3-5 part, Radix Glycyrrhizae 5-7 part, Radix Aucklandiae 3-5 part, Radix orixae japonicae 4-6 part, Borneolum Syntheticum 1-3 part.
Preferably, the Chinese medicine Shenkangsan-medicine for treating nephrosis of this treatment chronic renal failure is processed by following parts by weight of Chinese traditional medicine: 7 parts of Herba Epimedii, 2 parts of Semen Cuscutae, 6 parts of the Radixs Astragali, 4 parts of the Cortexs Eucommiae, 5 parts of Radix Curcumaes, 6 parts of Radix Angelicae Sinensis, 4 parts of Radix Salviae Miltiorrhizaes, 4 parts of Radix Morindae Officinaliss, 6 parts in Radix Glycyrrhizae, 4 parts of the Radix Aucklandiae, 5 parts of Radix orixae japonicaes, 2 parts of Borneolum Syntheticums.
Its preparation method is: get Herba Epimedii 7g, Semen Cuscutae 2g, Radix Astragali 6g, Cortex Eucommiae 4g, Radix Curcumae 5g, Radix Angelicae Sinensis 6g, Radix Salviae Miltiorrhizae 4g, Radix Morindae Officinalis 4g, Radix Glycyrrhizae 6g, Radix Aucklandiae 4g, Radix orixae japonicae 5g, Borneolum Syntheticum 2g.The grind up shape is subsequent use, earlier with ethanol routine disinfection umbilical part and all skin of umbilicus, gets the diffusing 6-8g of medicine-feeding during treatment; With 50 degree pure rice wine furnishing pasty states, the external application umbilical part is also sticked on musk rheumatic cream fixedly medicine is diffusing, the drug of topical application in 2 days 1 time; 6 weeks were 1 course of treatment, discharged 1-2 soft stool every day with patient and were advisable.
In the side: Herba Epimedii, Semen Cuscutae, the Radix Astragali, Cortex Eucommiae warming the kidney and strengthening the spleen, Radix Curcumae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae regulating qi to disperse stagnation, heart fire-clearing upset-relieving, stasis-dispelling and pain-killing, Radix Morindae Officinalis, Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, Radix Aucklandiae promoting the circulation of QI to relieve pain, intestinal stasis relieving in the accent; Radix orixae japonicae is good at warming spleen and stomach for dispelling cold and Borneolum Syntheticum, musk rheumatic cream can promote that other drug sees through absorption, and relieving accumulation of pathogens is capable to stagnate, the capable network that stimulates the menstrual flow, through sick institute.
Clinical data
1, physical data
All 160 cases are all come case in year February self-institute Nephrology in April, 2005-2007, and wherein 80 examples are organized in treatment, male 43 examples, women 37 examples; Age 25-67 year, average 48.5 years old; The course of disease 2.5 months-15 years; Protopathy: chronic nephritis 31 examples, diabetes 25 examples, gouty nephropathy 9 examples, chronic pyelonephritis 5 examples, hypertensive renal damage 5 examples, MCKD 5 examples.Matched group 80 examples, male 41 examples, women 39 examples; Age 24-66 year, average 47.8 years old, the course of disease 3 months-14 years; Protopathy: chronic nephritis 30 examples, diabetic nephropathy 26 examples, gouty nephropathy 9 examples, hypertension is damaged 4 examples, chronic pyelonephritis 6 examples, polycystic kidney 5 examples, two groups of ages, sex and sick plant, comparability is all arranged on the course of disease.
2, case choice criteria
The case inclusion criteria meets the Western medicine diagnose standard Chinese medical discrimination standard that academic conference is drafted with for the second time national traditional Chinese medical science nephropathy special topic that national renal failure conservative treatment in 1987 special meeting is worked out.
3, Therapeutic Method
The treatment group earlier with ethanol routine disinfection umbilical part and all skin of umbilicus, is got the diffusing 6-8g of medicine-feeding with Chinese medicine Shenkangsan-medicine for treating nephrosis external application umbilical part of the present invention during treatment; With 50 degree pure rice wine furnishing pasty states; The external application umbilical part and stick on musk rheumatic cream fixedly medicine loose, the drug of topical application in 2 days 1 time, 6 weeks were 1 course of treatment.
The each 5g of the oral Coated Aldehyde Oxystarch of matched group patient, every day 3 times, 6 weeks were 1 course of treatment.
4, efficacy assessment standard
Produce effects: 30% before sx or disappearance, the treatment of SCr decline horizontal exceeding; Effectively: 20% of sx, the preceding level of SCr decline horizontal exceeding treatment; Invalid: symptom does not have improvement, SCr treatment front and back no change or does not meet produce effects or effective Rule of judgment person.
5, therapeutic outcome
Two groups of patients all adopt the high-quality protein high caloric diet, and infect, correct Water-Electrolyte and acid base imbalance with doctor trained in Western medicine means control hypertension, treatment.Add up curative effect after 1 course of treatment: the treatment group: produce effects 29 examples (36.3%), effective 42 examples (52.5%), invalid 9 examples (11.3%), total effective rate 88.8%.Matched group: effective 38 examples of produce effects 18 examples (22.5%) (47.5%), invalid 24 examples (30.0%), total effective rate 70.0%.Two groups of obvious effective rates are checked through x2, and difference has significance.
The specific embodiment
Embodiment one: get Herba Epimedii 7g, Semen Cuscutae 2g, Radix Astragali 6g, Cortex Eucommiae 4g, Radix Curcumae 5g, Radix Angelicae Sinensis 6g, Radix Salviae Miltiorrhizae 4g, Radix Morindae Officinalis 4g, Radix Glycyrrhizae 6g, Radix Aucklandiae 4g, Radix orixae japonicae 5g, Borneolum Syntheticum 2g, the grind up shape is subsequent use, and elder generation is with ethanol routine disinfection umbilical part and all skin of umbilicus during treatment; Get the diffusing 6g of medicine-feeding; With 50 degree pure rice wine furnishing pasty states, the external application umbilical part is also sticked on musk rheumatic cream fixedly medicine is diffusing, the drug of topical application in 2 days 1 time; 6 weeks were 1 course of treatment, discharged 1-2 soft stool every day with patient and were advisable.
Embodiment two: get Herba Epimedii 6g, Semen Cuscutae 1g, Radix Astragali 7g, Cortex Eucommiae 3g, Radix Curcumae 4g, Radix Angelicae Sinensis 7g, Radix Salviae Miltiorrhizae 3g, Radix Morindae Officinalis 5g, Radix Glycyrrhizae 7g, Radix Aucklandiae 3g, Radix orixae japonicae 4g, Borneolum Syntheticum 3g, the grind up shape is subsequent use, and elder generation is with ethanol routine disinfection umbilical part and all skin of umbilicus during treatment; Get the diffusing 8g of medicine-feeding; With 50 degree pure rice wine furnishing pasty states, the external application umbilical part is also sticked on musk rheumatic cream fixedly medicine is diffusing, the drug of topical application in 2 days 1 time; 6 weeks were 1 course of treatment, discharged 1-2 soft stool every day with patient and were advisable.
Embodiment three: get Herba Epimedii 8g, Semen Cuscutae 3g, Radix Astragali 5g, Cortex Eucommiae 5g, Radix Curcumae 6g, Radix Angelicae Sinensis 5g, Radix Salviae Miltiorrhizae 5g, Radix Morindae Officinalis 3g, Radix Glycyrrhizae 5g, Radix Aucklandiae 5g, Radix orixae japonicae 6g, Borneolum Syntheticum 1g, the grind up shape is subsequent use, and elder generation is with ethanol routine disinfection umbilical part and all skin of umbilicus during treatment; Get the diffusing 7g of medicine-feeding; With 50 degree pure rice wine furnishing pasty states, the external application umbilical part is also sticked on musk rheumatic cream fixedly medicine is diffusing, the drug of topical application in 2 days 1 time; 6 weeks were 1 course of treatment, discharged 1-2 soft stool every day with patient and were advisable.

Claims (2)

1. Chinese medicine Shenkangsan-medicine for treating nephrosis of treating chronic renal failure is characterized in that this Chinese medicine Shenkangsan-medicine for treating nephrosis processed by following parts by weight of Chinese traditional medicine: Herba Epimedii 6-8 part, Semen Cuscutae 1-3 part, Radix Astragali 5-7 part, Cortex Eucommiae 3-5 part, Radix Curcumae 4-6 part, Radix Angelicae Sinensis 5-7 part, Radix Salviae Miltiorrhizae 3-5 part, Radix Morindae Officinalis 3-5 part, Radix Glycyrrhizae 5-7 part, Radix Aucklandiae 3-5 part, Radix orixae japonicae 4-6 part, Borneolum Syntheticum 1-3 part.
2. a kind of Chinese medicine Shenkangsan-medicine for treating nephrosis of treating chronic renal failure according to claim 1 is characterized in that this Chinese medicine Shenkangsan-medicine for treating nephrosis processed by following parts by weight of Chinese traditional medicine: 7 parts of Herba Epimedii, 2 parts of Semen Cuscutae, 6 parts of the Radixs Astragali, 4 parts of the Cortexs Eucommiae, 5 parts of Radix Curcumaes, 6 parts of Radix Angelicae Sinensis, 4 parts of Radix Salviae Miltiorrhizaes, 4 parts of Radix Morindae Officinaliss, 6 parts in Radix Glycyrrhizae, 4 parts of the Radix Aucklandiae, 5 parts of Radix orixae japonicaes, 2 parts of Borneolum Syntheticums.
CN 201110462849 2011-12-31 2011-12-31 Chinese medicinal kidney healing powder for treating chronic renal failure Expired - Fee Related CN102526614B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110462849 CN102526614B (en) 2011-12-31 2011-12-31 Chinese medicinal kidney healing powder for treating chronic renal failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110462849 CN102526614B (en) 2011-12-31 2011-12-31 Chinese medicinal kidney healing powder for treating chronic renal failure

Publications (2)

Publication Number Publication Date
CN102526614A true CN102526614A (en) 2012-07-04
CN102526614B CN102526614B (en) 2013-05-15

Family

ID=46335434

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110462849 Expired - Fee Related CN102526614B (en) 2011-12-31 2011-12-31 Chinese medicinal kidney healing powder for treating chronic renal failure

Country Status (1)

Country Link
CN (1) CN102526614B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105125814A (en) * 2015-10-19 2015-12-09 管遵信 Traditional Chinese medicine composite for treating chronic renal failure III and IV stages
CN105596609A (en) * 2015-11-02 2016-05-25 朱晓杰 Traditional Chinese medicine plaster used for treating uric acid nephropathy

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238201A (en) * 1998-06-05 1999-12-15 伊胜富 Shenkangsan-medicine for treating nephrosis
CN101066326A (en) * 2007-05-11 2007-11-07 徐朝阳 Chinese medicine for treating kidney deficiency and its prepn
CN101085294A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine for curing chronic renal failure
CN101380386A (en) * 2008-09-18 2009-03-11 何官平 Traditional Chinese medicine composition for tonifying the kidney yang
CN102114205A (en) * 2010-11-26 2011-07-06 易国松 Chinese herbal medicine for treating nephropathy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1238201A (en) * 1998-06-05 1999-12-15 伊胜富 Shenkangsan-medicine for treating nephrosis
CN101066326A (en) * 2007-05-11 2007-11-07 徐朝阳 Chinese medicine for treating kidney deficiency and its prepn
CN101085294A (en) * 2007-06-26 2007-12-12 北京艺信堂医药研究所 Traditional Chinese medicine for curing chronic renal failure
CN101380386A (en) * 2008-09-18 2009-03-11 何官平 Traditional Chinese medicine composition for tonifying the kidney yang
CN102114205A (en) * 2010-11-26 2011-07-06 易国松 Chinese herbal medicine for treating nephropathy

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105125814A (en) * 2015-10-19 2015-12-09 管遵信 Traditional Chinese medicine composite for treating chronic renal failure III and IV stages
CN105125814B (en) * 2015-10-19 2019-11-08 管遵信 It is a kind of to treat chronic renal failure III, the Chinese medicine composition of IV phase
CN105596609A (en) * 2015-11-02 2016-05-25 朱晓杰 Traditional Chinese medicine plaster used for treating uric acid nephropathy

Also Published As

Publication number Publication date
CN102526614B (en) 2013-05-15

Similar Documents

Publication Publication Date Title
CN102973685A (en) Anti-fatigue traditional Chinese medicine preparation and preparation method thereof
CN105056124A (en) Medicine for treating hypertension and diabetes
CN102357187A (en) Traditional Chinese medicine composition for treating acute lumbar sprain
CN1411830A (en) Medicine for curing hypertension and its preparation method
CN101507783B (en) Medicinal wine capable of treating lumbar disc protrusion
CN1977934A (en) Medicinal liquor for treating cervix vertebra disease and lumbar disc protrusion and its preparing method
CN101569699B (en) Pharmaceutical composition for treating prostatitis and preparation method thereof
CN103040976B (en) Medicine for promoting postoperative rehabilitation of facial nerve injury surgical anastomosis
CN102526614B (en) Chinese medicinal kidney healing powder for treating chronic renal failure
CN101181488A (en) Chinese medicine composition orally taken for curing osteosporosis
CN100509025C (en) A medicine for treating diabetes
CN102988892B (en) Medicament for treating hysteromyoma and ovarian cysts
CN103495108B (en) Medicine for treating chronic hypotension and preparation method for medicine
CN103006833B (en) Medicine for hiatus hernia postoperative rehabilitation
CN102293981B (en) Oral drug for treating oral ulcer
CN101961478A (en) Medicament for treating hyperosteogeny, rheumatism and rheumatoid diseases and preparation method thereof
CN101721622A (en) Traditional Chinese medicine for treating tension-type headache
CN101229360B (en) Anti-AIDS medicine
CN104689288B (en) A kind of Chinese medicine preparation for treating chronic hypotension
CN102949539A (en) Pure traditional Chinese medicine health care product granule used for treating vitiligo and preparation method thereof
CN103007236B (en) Chinese medicinal composition for treating ankylosing spondylitis
CN102935214A (en) Traditional Chinese medicinal composition for treating uremia
CN102327435A (en) Traditional Chinese herb preparation for treating gout
CN102824611B (en) Traditional Chinese medicine for treating menstrual disorder
CN102198201B (en) Traditional Chinese medicine composition for treating deficiency-cold headache

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130515

Termination date: 20131231